Michael Croft

535 total citations
10 papers, 439 citations indexed

About

Michael Croft is a scholar working on Immunology, Cancer Research and Molecular Biology. According to data from OpenAlex, Michael Croft has authored 10 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 8 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Michael Croft's work include NF-κB Signaling Pathways (8 papers), Immune Response and Inflammation (4 papers) and Retinoids in leukemia and cellular processes (2 papers). Michael Croft is often cited by papers focused on NF-κB Signaling Pathways (8 papers), Immune Response and Inflammation (4 papers) and Retinoids in leukemia and cellular processes (2 papers). Michael Croft collaborates with scholars based in United States, Japan and Switzerland. Michael Croft's co-authors include Takanori So, Jianxun Song, Hiroyasu Nakano, So-Young Eun, Amnon Altman, Morten Meldal, Irene Gramaglia, Carl F. Ware, Alessandra Franco and Laura Cipolla and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Immunology and The Journal of Immunology.

In The Last Decade

Michael Croft

10 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Croft United States 9 324 103 101 85 24 10 439
Kristina Drott Sweden 13 109 0.3× 100 1.0× 196 1.9× 51 0.6× 33 1.4× 24 338
Andrew Podd United States 7 304 0.9× 85 0.8× 73 0.7× 75 0.9× 54 2.3× 10 434
Chitra Sudarshan United States 8 388 1.2× 281 2.7× 155 1.5× 67 0.8× 22 0.9× 10 549
Bryan C. McIntosh United States 9 223 0.7× 196 1.9× 104 1.0× 36 0.4× 24 1.0× 13 445
Kate Sandstrom United States 9 256 0.8× 221 2.1× 99 1.0× 34 0.4× 17 0.7× 13 435
Kouji Kato Japan 8 244 0.8× 219 2.1× 119 1.2× 37 0.4× 57 2.4× 10 459
Reba M. Knox United States 8 156 0.5× 179 1.7× 82 0.8× 45 0.5× 14 0.6× 11 424
Melissa Mavers United States 12 285 0.9× 162 1.6× 105 1.0× 29 0.3× 81 3.4× 26 453
M. Betina Pampena Argentina 12 385 1.2× 333 3.2× 96 1.0× 28 0.3× 16 0.7× 23 562
Rosa Lovis United States 7 208 0.6× 74 0.7× 114 1.1× 67 0.8× 36 1.5× 9 408

Countries citing papers authored by Michael Croft

Since Specialization
Citations

This map shows the geographic impact of Michael Croft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Croft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Croft more than expected).

Fields of papers citing papers by Michael Croft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Croft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Croft. The network helps show where Michael Croft may publish in the future.

Co-authorship network of co-authors of Michael Croft

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Croft. A scholar is included among the top collaborators of Michael Croft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Croft. Michael Croft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gupta, Rinkesh Kumar, Donald T. Gracias, Haruka Miki, et al.. (2021). TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapy. Science Immunology. 6(65). eabi8823–eabi8823. 63 indexed citations
2.
Gupta, Rinkesh Kumar, Donald T. Gracias, Linda C. Burkly, & Michael Croft. (2020). Tumor necrosis factor like weak inducer of apoptosis (TWEAK) Promotes Inflammatory Activity in Keratinocytes with IL-17 and TNF to Drive Psoriasis. The Journal of Immunology. 204(1_Supplement). 237.1–237.1. 2 indexed citations
3.
Herro, Rana, Dennis Wolf, Konrad Buscher, et al.. (2017). The TWEAK/Fn14 pathway is required for calcineurin inhibitor toxicity of the kidneys. American Journal of Transplantation. 18(7). 1636–1645. 17 indexed citations
4.
Nagashima, Hiroyuki, Yuko Okuyama, Atsuko Asao, et al.. (2014). The adaptor TRAF5 limits the differentiation of inflammatory CD4+ T cells by antagonizing signaling via the receptor for IL-6. Nature Immunology. 15(5). 449–456. 40 indexed citations
5.
So, Takanori & Michael Croft. (2012). Regulation of the PKCθ-NF-κB Axis in T Lymphocytes by the Tumor Necrosis Factor Receptor Family Member OX40. Frontiers in Immunology. 3. 133–133. 17 indexed citations
6.
So, Takanori, Pejman Soroosh, So-Young Eun, Amnon Altman, & Michael Croft. (2011). Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells. Proceedings of the National Academy of Sciences. 108(7). 2903–2908. 48 indexed citations
7.
Song, Jianxun, Takanori So, & Michael Croft. (2008). Activation of NF-κB1 by OX40 Contributes to Antigen-Driven T Cell Expansion and Survival. The Journal of Immunology. 180(11). 7240–7248. 100 indexed citations
8.
So, Takanori, Shahram Salek‐Ardakani, Hiroyasu Nakano, Carl F. Ware, & Michael Croft. (2004). TNF Receptor-Associated Factor 5 Limits the Induction of Th2 Immune Responses. The Journal of Immunology. 172(7). 4292–4297. 50 indexed citations
9.
Lee, Tzong‐Hae, et al.. (2001). MICROCHIMERISM DOES NOT INDUCE TOLERANCE AND SUSTAINS IMMUNITY AFTER IN UTERO TRANSPLANTATION1. Transplantation. 71(3). 359–368. 30 indexed citations
10.
Franco, Alessandra, Irene Gramaglia, Michael Croft, et al.. (2000). Epitope affinity for MHC class I determines helper requirement for CTL priming. Nature Immunology. 1(2). 145–150. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026